论文部分内容阅读
静脉血栓栓塞(VTE)包括深静脉血栓(DVT)及肺动脉栓塞(PE)是临床常见病,严重者可危及生命。据统计,美国每年新发DVT病例约200万人,并发PE约60万人,其中致死性PE20万人,死亡约5万人,占人口总死亡原因的第三位,仅次于肿瘤及心肌梗死,而发展中国家每年约有3~6千万人发生DVT[1,2]。V
Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE) are common clinical diseases, serious cases can be life-threatening. Statistics show that in the United States, about 2 million new cases of DVT occur each year and about 60 million PE are concurrently developed. Among them, 200,000 are deadly PEs and 50,000 are dead, accounting for the third leading cause of death in the population after cancer and myocardium Infarct, and developing countries each year about 3-60 million people DVT [1,2]. V